Yikes, took this off my watchlist once I sold and only came across after seeing it being discussed. Hope those LT holders that didn't do any research aren't burning after "topping up" at the "ridiculously cheap" levels.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game